查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612552

生物銀行市場：按產品類型、樣本類型、儲存類型、應用、最終用戶 - 2025-2030 年全球預測

Biobanking Market by Product (Consumables, Equipment & Instruments, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Storage Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物銀行市場價值為703.3億美元，預計2024年將達到782.1億美元，複合年成長率為11.71%，到2030年將達到1527.5億美元。

生物銀行是指用於研究和臨床治療的生物樣本的收集、處理、儲存和管理，在推進個人化醫療、基因組學和藥物開發方面發揮重要作用。對生物銀行的需求源於對高品質生物材料的日益成長的需求，以支持生物醫學研究並在理解疾病和創新治療方法實現突破。其應用涵蓋多個領域，包括癌症研究、遺傳疾病研究和流行病學。最終用戶範圍從學術研究機構到製藥公司和醫院。影響生物銀行市場的關鍵成長要素包括慢性病的擴散、再生醫學的進步以及研發活動資金的增加。精準醫療的日益普及使得這一點變得更加重要。然而，生物銀行面臨嚴格的監管要求、隱私和同意方面的道德問題以及樣本儲存和保存技術方面的挑戰等限制。此外，生物庫之間有限的資料存取和互通性也阻礙了進展。市場的新機會包括人工智慧和巨量資料分析的整合，以增強資料管理和解釋。此外，移動和分散式生物銀行方法的發展可以擴大樣本的多樣性和代表性。業務成長的創新部分包括創建用於樣本處理的標準化通訊協定和用於安全資料共用的區塊鏈應用程式。改善社區參與和培養社會信任對於克服道德挑戰和鼓勵參與生物銀行舉措仍然很重要。生物銀行市場的本質是競爭性和協作性的，生物技術公司、學術機構和醫療保健提供者之間有機會建立夥伴關係。進入這一領域的公司應專注於加強技術基礎設施並形成策略聯盟，以有效利用新技術。總體而言，生物銀行處於變革性醫療保健解決方案的前沿，研究和創新對於釋放其潛力至關重要。

主要市場統計
基準年[2023] 703.3億美元
預測年份 [2024] 782.1億美元
預測年份 [2030] 1527.5億美元
複合年成長率（%） 11.71%

市場動態：揭示快速發展的生物銀行市場的關鍵市場洞察

供需的動態交互作用正在改變生物銀行市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 整個經濟的慢性病負擔日益加重，需要改善醫療基礎設施
    • 增加私人和公共對藥物研究的投資
    • 人們對再生醫學和政府措施的認知不斷增強
  • 市場限制因素
    • 由於生物樣本庫的分散性質而導致程序統一的相關問題
  • 市場機會
    • 持續研究以改善和標準化生物樣本庫的資料收集和分析
    • 人們越來越關注生物樣本庫的永續性和成像生物樣本庫的發展
  • 市場問題
    • 與生物銀行相關的道德和法律問題

波特五力：駕馭生物銀行市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解生物銀行市場的外部影響

外部宏觀環境因素在塑造生物銀行市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解生物銀行市場的競爭格局

對生物銀行市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：生物銀行市場供應商的績效評估

FPNV定位矩陣是評估生物銀行市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製生物銀行市場的成功之路

生物銀行市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病負擔在整個經濟中增加，需要改善衛生基礎設施
      • 增加私人和公共對藥物研究的投資
      • 人們對再生醫學和政府措施的認知不斷增強
    • 抑制因素
      • 與透過生物樣本庫分散化協調程序相關的問題
    • 機會
      • 正在進行的研究以改善和確保生物樣本庫資料收集和分析的標準化
      • 人們越來越關注生物樣本庫的永續性和成像生物樣本庫的發展
    • 任務
      • 與生物銀行相關的道德和法律問題
  • 市場區隔分析
    • 產品：擴展軟體整合以簡化生物銀行操作
    • 樣本類型：在基因研究中增加核酸樣本的使用
    • 儲存類型：由於效率和可擴充性，自動化儲存系統越來越受青睞。
    • 最終用戶：擴大生物樣本庫在製藥領域的藥物開發
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章生物銀行市場：依產品

  • 介紹
  • 消耗品
  • 器材與設備
  • 服務
  • 軟體

第7章生物銀行市場：依樣本類型

  • 介紹
  • 體液
  • 血液製品
  • 細胞株
  • 人體組織
  • 核酸

第8章生物銀行市場：依儲存類型

  • 介紹
  • 自動的
  • 手動的

第9章生物銀行市場：依應用分類

  • 介紹
  • 臨床研究
  • 生命科學研究
  • 再生醫學

第 10 章生物銀行市場：按最終用戶分類

  • 介紹
  • 學術研究所
  • 醫院
  • 製藥/生物技術

第11章美洲生物銀行市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太生物銀行市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的生物銀行市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 新的生物銀行夥伴關係關係保護美國瀕危物種的遺傳多樣性
    • Crown Bioscience 收購 Indivumed 的服務業務並支持生物樣本庫
    • CNIO生物銀行從歐盟獲得80萬歐元
  • 戰略分析和建議

公司名單

  • AMS BIoTechnology（Europe）Limited
  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Life Sciences
  • Bay Biosciences LLC
  • Becton, Dickinson and Company
  • BioIVT LLC
  • BioKryo by L'AIR LIQUIDE SA
  • BocaBio
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBIoTech
  • Cureline, Inc.
  • Firalis Group
  • Greiner AG
  • Hamilton Company
  • Merck KgaA
  • Micronic Holding BV
  • PHC Holdings Corporation
  • Promega Corporation
  • ProteoGenex
  • QIAGEN NV
  • Sopachem NV/SA
  • SPT Labtech Ltd.
  • STEMCELL Technologies Inc.
  • Taylor-Wharton
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited
  • US Biolab Corporation, Inc.
Product Code: MRR-961BA04A2DC3

The Biobanking Market was valued at USD 70.33 billion in 2023, expected to reach USD 78.21 billion in 2024, and is projected to grow at a CAGR of 11.71%, to USD 152.75 billion by 2030.

Biobanking refers to the collection, processing, storage, and management of biological samples for research and clinical care, playing an essential role in advancing personalized medicine, genomics, and drug development. The necessity of biobanking arises from the growing need for high-quality biomaterials to support biomedical research, enabling breakthroughs in disease understanding and therapeutic innovation. Its applications span across various domains, including cancer research, genetic disorder studies, and epidemiology. End-users range from academic and research institutions to pharmaceutical companies and hospitals. Key growth factors influencing the biobanking market include the surge in chronic disease prevalence, advancements in regenerative medicine, and increased funding for R&D activities. The expanding adoption of precision medicine further amplifies its importance. However, biobanking faces limitations such as stringent regulatory requirements, ethical concerns regarding privacy and consent, and challenges in sample storage and preservation technologies. Moreover, limited data access and interoperability between biobanks can impede progress. Emerging opportunities in the market include the integration of artificial intelligence and big data analytics to enhance data management and interpretation. Additionally, the development of mobile and decentralized biobanking approaches can broaden sample diversity and representation. Innovative areas for business growth include the creation of standardized protocols for sample handling and blockchain applications for secure data sharing. Improving community engagement and fostering public trust remain critical to overcoming ethical challenges and boosting participation in biobanking initiatives. The nature of the biobanking market is competitive yet collaborative, with opportunities for partnerships among biotechnology firms, academic institutions, and healthcare providers. Companies venturing into this space should focus on enhancing their technological infrastructure and forming strategic alliances to harness emerging technologies effectively. Overall, biobanking stands at the forefront of transformative healthcare solutions, with research and innovation being pivotal to unlocking its potential.

KEY MARKET STATISTICS
Base Year [2023] USD 70.33 billion
Estimated Year [2024] USD 78.21 billion
Forecast Year [2030] USD 152.75 billion
CAGR (%) 11.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biobanking Market

The Biobanking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
    • Growing private and public investments in pharmaceutical research
    • Rising awareness and government initiatives in regenerative medicine
  • Market Restraints
    • Problems associated with procedure harmonization due to decentralized nature of biobanks
  • Market Opportunities
    • Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
    • Emerging focus on biobank sustainability and development of imaging biobanks
  • Market Challenges
    • Ethical and legal concerns associated with biobanking

Porter's Five Forces: A Strategic Tool for Navigating the Biobanking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biobanking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biobanking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biobanking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biobanking Market

A detailed market share analysis in the Biobanking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biobanking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biobanking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biobanking Market

A strategic analysis of the Biobanking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L'AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..

Market Segmentation & Coverage

This research report categorizes the Biobanking Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Equipment & Instruments, Services, and Software.
  • Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids.
  • Based on Storage Type, market is studied across Automated and Manual.
  • Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Pharmaceutical & Biotechnology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
      • 5.1.1.2. Growing private and public investments in pharmaceutical research
      • 5.1.1.3. Rising awareness and government initiatives in regenerative medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with procedure harmonization due to decentralized nature of biobanks
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
      • 5.1.3.2. Emerging focus on biobank sustainability and development of imaging biobanks
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and legal concerns associated with biobanking
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding software integration to facilitate the biobanking operations
    • 5.2.2. Sample Type: Increasing use of nucleic acid sample for genetic study
    • 5.2.3. Storage Type: Rising preference for automated storage systems due to its efficiency and scalability
    • 5.2.4. End-User: Expansion of biobanks in pharmaceutical sector for drug development
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biobanking Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment & Instruments
  • 6.4. Services
  • 6.5. Software

7. Biobanking Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Biological Fluids
  • 7.3. Blood Products
  • 7.4. Cell Lines
  • 7.5. Human Tissues
  • 7.6. Nucleic Acids

8. Biobanking Market, by Storage Type

  • 8.1. Introduction
  • 8.2. Automated
  • 8.3. Manual

9. Biobanking Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Research
  • 9.3. Life Science Research
  • 9.4. Regenerative Medicine

10. Biobanking Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Hospitals
  • 10.4. Pharmaceutical & Biotechnology

11. Americas Biobanking Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Biobanking Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Biobanking Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. New biobanking partnership safeguards the genetic diversity of America's endangered species
    • 14.3.2. Crown Bioscience to Acquire Indivumed's Service Business and Supporting Biobank
    • 14.3.3. CNIO biobank receives EUR 800,000 from the EU
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AMS Biotechnology (Europe) Limited
  • 2. ASKION GmbH
  • 3. Avantor, Inc.
  • 4. Azenta Life Sciences
  • 5. Bay Biosciences LLC
  • 6. Becton, Dickinson and Company
  • 7. BioIVT LLC
  • 8. BioKryo by L'AIR LIQUIDE S.A.
  • 9. BocaBio
  • 10. Charles River Laboratories International, Inc.
  • 11. Cryoport Systems, LLC
  • 12. CTIBiotech
  • 13. Cureline, Inc.
  • 14. Firalis Group
  • 15. Greiner AG
  • 16. Hamilton Company
  • 17. Merck KgaA
  • 18. Micronic Holding B.V.
  • 19. PHC Holdings Corporation
  • 20. Promega Corporation
  • 21. ProteoGenex
  • 22. QIAGEN N.V.
  • 23. Sopachem NV/SA
  • 24. SPT Labtech Ltd.
  • 25. STEMCELL Technologies Inc.
  • 26. Taylor-Wharton
  • 27. Tecan Trading AG
  • 28. Thermo Fisher Scientific Inc.
  • 29. UK Biobank Limited
  • 30. US Biolab Corporation, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOBANKING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOBANKING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOBANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOBANKING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOBANKING MARKET SIZE, BY EQUIPMENT & INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOBANKING MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOBANKING MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOBANKING MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOBANKING MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOBANKING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOBANKING MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOBANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOBANKING MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOBANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOBANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2023